Does Molecular Genotype Provide Useful Information in the Management of Radioiodine Refractory Thyroid Cancers? Results of a Retrospective Study. En savoir plus sur Does Molecular Genotype Provide Useful Information in the Management of Radioiodine Refractory Thyroid Cancers? Results of a Retrospective Study.
Gene and Survival in Patients with Ovarian Cancer. En savoir plus sur Gene and Survival in Patients with Ovarian Cancer.
-Mutated Hormone Receptor-Positive Advanced Breast Cancer. En savoir plus sur -Mutated Hormone Receptor-Positive Advanced Breast Cancer.
Actionable molecular alterations in advanced gynaecologic malignancies: updated results from the ProfiLER programme. En savoir plus sur Actionable molecular alterations in advanced gynaecologic malignancies: updated results from the ProfiLER programme.
Clinical factors associated with prolonged response and survival under olaparib as maintenance therapy in BRCA mutated ovarian cancers. En savoir plus sur Clinical factors associated with prolonged response and survival under olaparib as maintenance therapy in BRCA mutated ovarian cancers.
Decision of adjuvant chemotherapy in intermediate risk luminal breast cancer patients: A prospective multicenter trial assessing the clinical and psychological impact of EndoPredict® (EpClin) use (UCBG 2-14). En savoir plus sur Decision of adjuvant chemotherapy in intermediate risk luminal breast cancer patients: A prospective multicenter trial assessing the clinical and psychological impact of EndoPredict® (EpClin) use (UCBG 2-14).
Eight years tumor control with pazopanib for a metastatic resistant epithelioid hemangioendothelioma. En savoir plus sur Eight years tumor control with pazopanib for a metastatic resistant epithelioid hemangioendothelioma.